Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Stock-based Compensation

v3.24.1.u1
Note 12 - Stock-based Compensation
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

12.         Stock-based Compensation

 

The Company's Amended and Restated 2014 Equity Incentive Plan (the "2014 Plan") expired on  January 31, 2024. Following such expiration, no grants  may be made under the 2014 Plan, but the grants in effect prior to such expiration were not impacted by the expiration. 

 

Stock Options

 

The following table summarizes information about the Company’s stock options outstanding as of March 31, 2024, and activity during the three months then ended:

 

                   

Weighted-

         
                   

Average

         
           

Weighted-

   

Remaining

   

Aggregate

 
   

Stock

   

Average

   

Contractual

   

Intrinsic

 
   

Awards

   

Exercise Price

   

Life (Years)

   

Value

 

Balance as of December 31, 2023

    252     $ 36.17                  

Options cancelled

    (55 )     37.54                  

Balance as of March 31, 2024

    197     $ 37.79       4.26     $  

Vested and expected to vest as of March 31, 2024

    197     $ 37.79       4.26     $  

Exercisable as of March 31, 2024

    196     $ 37.80       4.26     $  

 

There were no stock options awarded during the three months ended March 31, 2024 and 2023, and no unrecognized compensation cost related to unvested stock options as of March 31, 2024.

 

Restricted Stock Units

 

The Company issues time-based restricted stock units (“RSUs”) and performance-based restricted stock units ("PSUs") to employees and non-employee members of the Board. Each RSU and PSU represents the right to receive one share of the Company’s common stock upon vesting and subsequent settlement. PSUs vest upon achievement of performance targets based on the Company's annual operating plan. The fair values of RSUs and PSUs are determined based on the closing price of the Company’s common stock on the date of grant.

 

Combined RSU and PSU activity for the three months ended March 31, 2024 is summarized below:

 

           

Weighted-

 
   

Number of

   

Average Grant

 
   

Shares

   

Date Fair Value

 

Unvested as of December 31, 2023

    1,305     $ 1.67  

Vested

    (172 )     1.87  

Unvested as of March 31, 2024

    1,133     $ 1.64  

 

As of March 31, 2024, $1,007 of total unrecognized compensation expense related to unvested RSUs and PSUs was expected to be recognized over a weighted average period of 1.30 years.

 

Compensation Expense

 

Stock-based compensation expense is included in the condensed consolidated statements of operations and comprehensive loss in general and administrative, research and development, or sales and marketing expenses, depending on the nature of the services provided. Stock-based compensation expense related to options, RSUs and PSUs was recorded as follows:

 

   

Three Months Ended March 31,

 
   

2024

   

2023

 

Sales and marketing

  $ 52     $ 64  

Research and development

    91       82  

General and administrative

    233       278  
    $ 376     $ 424  

 

401(k) Plan Share Match

 

During the three months ended March 31, 2024, the Company issued 163 shares of common stock with a fair value of $237, to eligible employees’ deferral accounts for the 401(k) Plan matching contribution representing 50% of each eligible employee’s elected deferral (up to the statutory limit) for the years ended December 31, 2023. No shares related to the 401(k) Plan matching contribution were issued during the three months ended March 31, 2023. 

 

The expense for the 401(k) Plan share matching was $29 and $93 for the three months ended March 31, 2024 and 2023, respectively.